Life Sciences

  • Twitter
  • Linkedin
Life Sciences
Cost Segregation Life Sciences

Why Cost Segregation Is a Strategic Tax Tool for Life Science Companies 

The life sciences sector is uniquely capital-intensive, highly regulated, and driven by continuous innovation. Pharmaceutical manufacturers, biotechnology firms, medical device companies, and contract research organizations (CROs) routinely invest tens or hundreds of millions of dollars into highly specialized facilities designed to support research, testing, manufacturing, and quality assurance activities.  While tax planning conversations in life [&he...